Aspen Pharmacare | APN - Gross Profit On Sales

Stock Price
13,794.00
Daily Change
-148.00 -1.06%
Monthly
6.76%
Yearly
15.61%
Q2 Forecast
13,633.48

Aspen Pharmacare reported ZAR10.14B in Gross Profit on Sales for its fiscal semester ending in June of 2024.





Gross Profit On Sales Change Date
Aspen Pharmacare ZAR 10.14B 830M Jun/2024
Cipla INR 39.1B 2.54B Mar/2026
Dr.Reddys Laboratories INR 37.77B 13.6B Mar/2026
Jiangsu Hengrui CNY 7.27B 918.27M Dec/2025
Kalbe Farma IDR 3.45T 151.13B Sep/2025
Life Healthcare ZAR 14.66B 1.12B Dec/2022
Netcare ZAR 5.51B 475M Dec/2022
Richter Gedeon HUF 143.37B 25.78B Sep/2025